MIRA Pharmaceuticals Inc./$MIRA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
Ticker
$MIRA
Sector
Primary listing
Employees
-
Headquarters
Website
MIRA Metrics
BasicAdvanced
$44m
-
-$1.35
1.94
-
Price and volume
Market cap
$44m
Beta
1.94
52-week high
$2.45
52-week low
$0.90
Average daily volume
177k
Financial strength
Current ratio
15.751
Quick ratio
15.711
Total debt to equity
5.513
Profitability
Management effectiveness
Return on assets (TTM)
-93.58%
Return on equity (TTM)
-165.87%
Valuation
Price to book
4.24
Price to tangible book (TTM)
4.24
Price to free cash flow (TTM)
-5.337
Free cash flow yield (TTM)
-18.74%
Free cash flow per share (TTM)
-0.197
Growth
Earnings per share change (TTM)
165.61%
3-year earnings per share growth (CAGR)
49.79%
MIRA News
AllArticlesVideos
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies
Accesswire·1 month ago
MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2
Accesswire·2 months ago
MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study
Accesswire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MIRA Pharmaceuticals Inc. stock?
MIRA Pharmaceuticals Inc. (MIRA) has a market cap of $44M as of May 01, 2026.
What is the P/E ratio for MIRA Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for MIRA Pharmaceuticals Inc. (MIRA) stock is 0 as of May 01, 2026.
Does MIRA Pharmaceuticals Inc. stock pay dividends?
No, MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders as of May 01, 2026.
When is the next MIRA Pharmaceuticals Inc. dividend payment date?
MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders.
What is the beta indicator for MIRA Pharmaceuticals Inc.?
MIRA Pharmaceuticals Inc. (MIRA) has a beta rating of 1.94. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.